Lloyd Kunimoto

Partner and Chief Business Officer

Lloyd Kunimoto joined Flagship Ventures in 2014 and focuses on corporate business development and strategic partnerships for the firm’s VentureLabsTM companies. Lloyd brings more than 25 years of experience successfully leading agricultural biotechnology and biopharmaceutical companies.

Prior to joining Flagship, Lloyd was the Chief Business Officer of Sapphire Energy where he was responsible for establishing corporate partnerships to lead Sapphire’s commercial development. He was previously Senior Vice President of Corporate Development at Pacific Biosciences and Vice President, Corporate Strategy for Monsanto. At Monsanto he was responsible for broadening Monsanto’s access to cutting-edge technologies through R&D collaborations, licensing agreements and partnerships with venture capital firms specializing in life science investing. Prior to Monsanto, Lloyd was President and CEO of two venture capital-backed biopharmaceutical companies, Galileo Pharmaceuticals and Epicyte Pharmaceuticals, and was Senior Vice President of Corporate Development at Exelixis, Inc., a publicly traded biopharmaceutical company developing small-molecule cancer and metabolic disease therapeutics, with responsibility for business development, mergers and acquisitions and intellectual property.

Lloyd received a BS in Mathematics from Stanford University.